Literature DB >> 30097301

Telemedicine's Role in Addressing the Opioid Epidemic.

Y Tony Yang1, Eric Weintraub2, Rebecca L Haffajee3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30097301      PMCID： PMC6330237          DOI： 10.1016/j.mayocp.2018.07.001

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  10 in total

1.  Drug Overdose Deaths in the United States, 1999-2016.

Authors:  Holly Hedegaard; Margaret Warner; Arialdi M Miniño
Journal:  NCHS Data Brief       Date:  2017-12

Review 2.  Oral naltrexone maintenance treatment for opioid dependence.

Authors:  Silvia Minozzi; Laura Amato; Simona Vecchi; Marina Davoli; Ursula Kirchmayer; Annette Verster
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

3.  The untapped potential of office-based buprenorphine treatment.

Authors:  Stacey C Sigmon
Journal:  JAMA Psychiatry       Date:  2015-04       Impact factor: 21.596

4.  National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment.

Authors:  Christopher M Jones; Melinda Campopiano; Grant Baldwin; Elinore McCance-Katz
Journal:  Am J Public Health       Date:  2015-06-11       Impact factor: 9.308

5.  The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting.

Authors:  Joseph K Eibl; Graham Gauthier; David Pellegrini; Jeffery Daiter; Michael Varenbut; John C Hogenbirk; David C Marsh
Journal:  Drug Alcohol Depend       Date:  2017-05-17       Impact factor: 4.492

6.  Treatment Outcome Comparison Between Telepsychiatry and Face-to-face Buprenorphine Medication-assisted Treatment for Opioid Use Disorder: A 2-Year Retrospective Data Analysis.

Authors:  Wanhong Zheng; Michael Nickasch; Laura Lander; Sijin Wen; Minchan Xiao; Patrick Marshalek; Ebony Dix; Carl Sullivan
Journal:  J Addict Med       Date:  2017 Mar/Apr       Impact factor: 3.702

7.  Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009.

Authors:  Robert P Schwartz; Jan Gryczynski; Kevin E O'Grady; Joshua M Sharfstein; Gregory Warren; Yngvild Olsen; Shannon G Mitchell; Jerome H Jaffe
Journal:  Am J Public Health       Date:  2013-03-14       Impact factor: 9.308

Review 8.  Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.

Authors:  R P Mattick; J Kimber; C Breen; M Davoli
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 9.  The effectiveness of telemental health: a 2013 review.

Authors:  Donald M Hilty; Daphne C Ferrer; Michelle Burke Parish; Barb Johnston; Edward J Callahan; Peter M Yellowlees
Journal:  Telemed J E Health       Date:  2013-06       Impact factor: 3.536

10.  Vital Signs: Trends in Emergency Department Visits for Suspected Opioid Overdoses - United States, July 2016-September 2017.

Authors:  Alana M Vivolo-Kantor; Puja Seth; R Matthew Gladden; Christine L Mattson; Grant T Baldwin; Aaron Kite-Powell; Michael A Coletta
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-03-09       Impact factor: 17.586
  10 in total
  14 in total

1.  Leveraging Telehealth in the United States to Increase Access to Opioid Use Disorder Treatment in Pregnancy and Postpartum During the COVID-19 Pandemic.

Authors:  Constance Guille; Jenna L McCauley; Angela Moreland
Journal:  Am J Psychiatry       Date:  2021-04-01       Impact factor: 18.112

Review 2.  Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers within the Treatment System.

Authors:  Bertha K Madras; N Jia Ahmad; Jenny Wen; Joshua Sharfstein Sharfstein
Journal:  NAM Perspect       Date:  2020-04-27

3.  Innovation During COVID-19: Improving Addiction Treatment Access.

Authors:  Elizabeth A Samuels; Seth A Clark; Caroline Wunsch; Lee Ann Jordison Keeler; Neha Reddy; Rahul Vanjani; Rachel S Wightman
Journal:  J Addict Med       Date:  2020 Jul/Aug       Impact factor: 3.702

4.  COVID-19 Adaptations in the Care of Patients with Opioid Use Disorder: a Survey of California Primary Care Clinics.

Authors:  Lauren Caton; Hannah Cheng; Hélène Chokron Garneau; Tammy Fisher; Briana Harris-Mills; Brian Hurley; Sandra Newman; Mark P McGovern
Journal:  J Gen Intern Med       Date:  2021-01-28       Impact factor: 5.128

5.  A Blueprint for the Conduct of Large, Multisite Trials in Telemedicine.

Authors:  Patricia Commiskey; April W Armstrong; Tumaini R Coker; Earl Ray Dorsey; John C Fortney; Kenneth J Gaines; Brittany M Gibbons; Huong Q Nguyen; Daisy R Singla; Eva Szigethy; Elizabeth A Krupinski
Journal:  J Med Internet Res       Date:  2021-09-20       Impact factor: 5.428

6.  An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19.

Authors:  G Caleb Alexander; Kenneth B Stoller; Rebecca L Haffajee; Brendan Saloner
Journal:  Ann Intern Med       Date:  2020-04-02       Impact factor: 25.391

7.  National U.S. time-trends in opioid use disorder hospitalizations and associated healthcare utilization and mortality.

Authors:  Jasvinder A Singh; John D Cleveland
Journal:  PLoS One       Date:  2020-02-18       Impact factor: 3.240

8.  Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19.

Authors:  Corey S Davis; Elizabeth A Samuels
Journal:  Int J Drug Policy       Date:  2020-08-15

9.  Use and Content of Primary Care Office-Based vs Telemedicine Care Visits During the COVID-19 Pandemic in the US.

Authors:  G Caleb Alexander; Matthew Tajanlangit; James Heyward; Omar Mansour; Dima M Qato; Randall S Stafford
Journal:  JAMA Netw Open       Date:  2020-10-01

10.  Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine.

Authors:  Lori Uscher-Pines; Jessica Sousa; Pushpa Raja; Ateev Mehrotra; Michael Barnett; Haiden A Huskamp
Journal:  J Subst Abuse Treat       Date:  2020-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.